L
Louis Malspeis
Researcher at Ohio State University
Publications - 66
Citations - 3346
Louis Malspeis is an academic researcher from Ohio State University. The author has contributed to research in topics: Pharmacokinetics & High-performance liquid chromatography. The author has an hindex of 25, co-authored 66 publications receiving 3261 citations. Previous affiliations of Louis Malspeis include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent.
TL;DR: In consideration of the potential for acute hepatotoxic reactions to GM, as well as to the other benzoquinoid ansamycins based upon structural analogy, additional pharmacological and therapeutic information is required to ascertain whether these compounds are viable candidates for clinical development.
Journal ArticleDOI
Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data.
TL;DR: Halichondrin B was compared with other agents which interfere with the binding of vinca alkaloids to tubulin in terms of its effects on tubulin polymerization, inhibition of GTP hydrolysis, inhibited of nucleotide exchange, and stabilization of tubulin, as well as the quantitative assessment of its effect on vincA alkaloid binding and inhibition of cell growth.
Journal ArticleDOI
In vivo cultivation of tumor cells in hollow fibers.
Melinda G. Hollingshead,Michael C. Alley,Richard F. Camalier,B. J. Abbott,Joseph G. Mayo,Louis Malspeis,Michael R. Grever +6 more
TL;DR: Results of experimentation to date demonstrate that a hollow fiber encapsulation/implantation methodology provides quantitative indices of drug efficacy with minimum expenditures of time and materials.
Journal ArticleDOI
Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS
William G. Rice,Jeffrey G. Supko,Louis Malspeis,Robert W. Buckheit,David J. Clanton,Ming Bu,Lisa Graham,Catherine A. Schaeffer,Jim A. Turpin,John M. Domagala,Rocco D. Gogliotti,John P. Bader,Susan M. Halliday,Lori V. Coren,Raymond C. Sowder,Larry O. Arthur,Louis E. Henderson +16 more
TL;DR: Nontoxic disulfide-substituted benzamides were identified that attack the zinc fingers, inactivate cell-free virions, inhibit acute and chronic infections, and exhibit broad antiretroviral activity.
Journal Article
Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data.
TL;DR: Data generated in the new National Cancer Institute drug evaluation program, which are based on inhibition of cell growth in 60 human tumor cell lines, were probed with nine known antimitotic agents using the COMPARE algorithm to have great promise for the identification of new antimitosis agents with antineoplastic potential.